Q2 Earnings Forecast for Chemours Issued By Zacks Research
The Chemours Company (NYSE:CC – Free Report) – Stock analysts at Zacks Research reduced their Q2 2025 earnings estimates for Chemours in a research note issued to investors on Monday, March 3rd. Zacks Research analyst R. Department now expects that the specialty chemicals company will earn $0.58 per share for the quarter, down from their […]
